Related Experiment Video
Updated: May 6, 2026
12:00
Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
Published on: January 22, 2015
11.4K
Chitosan-Graphene Composite for Drug Delivery in Cancer Therapy: Recent Progress and Advances
Negar Lari Lavasani1, Mohammad Hossein Roozbahani1, Seyed Morteza Naghib1
1Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology, 1684613114, Tehran, Iran.
Anti-Cancer Agents in Medicinal Chemistry
|May 5, 2026
Summary
Graphene/chitosan nanocomposites show promise for anticancer drug delivery due to their unique properties. This combination enhances drug efficacy and offers biocompatibility for cancer therapy applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Therapy
Background:
- Chitosan (CS) is a biodegradable, non-toxic biopolymer with antibacterial properties, ideal for therapeutic applications.
- Graphene oxide is biocompatible, cost-effective, and non-toxic, suitable for diverse applications.
- Graphene/chitosan nanocomposites offer unique physical, chemical, and electrical properties for enhanced drug delivery.
Purpose of the Study:
- To review anticancer drug delivery systems utilizing graphene/chitosan (CS) nanocomposites.
- To explore the potential of chitosan/graphene oxide composites in wound dressings and cancer therapy.
- To examine the combined benefits of chitosan and graphene for enhanced therapeutic outcomes.
Main Methods:
- Literature review of existing research on graphene/chitosan nanocomposites for drug delivery.
- Analysis of the properties of chitosan and graphene oxide relevant to biomedical applications.
- Investigation into the synergistic effects of combining chitosan and graphene.
Main Results:
- Graphene/chitosan nanocomposites demonstrate improved drug efficacy in delivery systems.
- Chitosan's inherent properties and graphene oxide's biocompatibility make them suitable for cancer treatment.
- The combination of CS and graphene is under investigation for enhanced therapeutic benefits.
Conclusions:
- Graphene/chitosan nanocomposites represent a promising platform for advanced anticancer drug delivery.
- The synergistic combination of chitosan and graphene offers significant potential for cancer therapy and wound healing.
- Further research into these nanocomposites could lead to more effective cancer treatment strategies.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165
02:57Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
01:16Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
02:49Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
336
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
336
01:24Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167